Despite the diverse developmental origins of vascular smooth muscle cells (VSMCs), recent attempts to generate VSMCs from human embryonic stem cells (hESCs) differentiated along various lineages did not yield distinct cell phenotypes. The aim of this study was to derive and characterize functional coronary-like VSMCs from hESCs using serum-free cardiac-directed differentiation.
Introduction
Vascular smooth muscle cells (VSMCs) are derived from a complex and diverse population of precursor cells during embryonic development. Fate-mapping studies indicate that VSMCs of the coronary artery are derived from the proepicardium and the proepicardial mesothelium, which represent somatic and splanchnic tissues of lateral plate mesoderm. 1 In contrast, VSMCs of aortic root originate from the secondary heart field, 2 whereas those of aortic arch are derived from neural crest. 3 Correspondingly, previous studies have derived SMC-like cells from diverse sources such as embryonic stem cells (ESCs), 4 cardiac-directed progenitors, 5 neural crest-derived stem cells, 6, 7 skin-derived progenitors, 8 and other human adult tissues. 9 -13 Having said this, current human ESC systems do not accurately reproduce mature SMCs based on precise lineage specification. 14, 15 Human ESCs represent a unique source of VSMCs given their unparalleled ability to yield specific lineages. Indeed, methods to derive specific VSMCs from hESCs might serve as a promising platform for regenerative medicine. 16 -18 Although many studies have reported striking differentiation capacity of hESCs towards SMC-like cells, the majority have included the serum, which represents an immunogenic and pleiotropic hazard. 19, 20 Ill-defined combinations of factors, together with inherent variability between lots, further limit the reproducibility of serum-based protocols. Moreover, these protocols have not been optimized for the generation of specific SMC lineages.
To date, studies have not characterized the stability of SMC-specific gene and protein expression and function over several passages. We believe that a mature and functional SMC population derived from hESCs had not been demonstrated as stable, or thoroughly compared with human SMCs from distinct lineages. It has also been suggested that SMCs of varying embryonic origins when tested under identical conditions in vivo respond in lineage-specific ways to factors that control development, growth, and tissue remodelling. 21, 22 In recent work by Cheung et al. 23 a chemically defined method to derive lineage-specific VSMCs from human pluripotent stem cells yielded no clear phenotypic and functional differences between SMC subtypes, which were compared only with primary human aortic SMCs. However, these authors did not direct differentiation towards any specific organ. We hypothesized that environmental cues of a specific organ are needed for mature phenotypic and functional differences to emerge in its developing VSMCs. In the current study, we identify developmental stage with lineage-specific populations of VSMCs derived from cardiac-directed hESCs differentiation in serum-free conditions. Importantly, our chemically defined protocol promotes cardiac differentiation from lateral plate mesoderm without induction of somatic mesoderm markers. 24 Embryoid bodies (EBs) differentiated under this protocol are composed of endothelial cells (ECs), cardiomyocytes (CMs), fibroblasts, and VSMCs, and yield a distinct subpopulation of VSMCs by d28. These VSMCs were subsequently characterized over multiple passages, and compared with mature primary human SMCs from three distinct developmental origins. Over several passages, hESC-derived VSMCs from our cardiacdirected protocol were highly enriched and expressed multiple mature SMC-specific genes and proteins, containing all the cellular components required for Ca 2+ cycling and contraction in response to agonists. Importantly, these hESCs-derived VSMCs were functionally and phenotypically indistinguishable to human coronary artery SMCs (hCSMCs) and clearly different from human aorta and human bladder SMCs (hASMCs and hBSMCs). Finally, we demonstrate that our hESC-derived 'coronary-like' VSMCs are capable of integrating into and participating in vasculogenesis in vivo.
Methods

Maintenance and differentiation of hESCs
hESC line HES2 and H7 [NIH code ES02 from ES Cell International (ESI) and Wi Cell product number WA07, respectively] and the hiPS lines, MSC-iPS1 (also known as Y2-1 was maintained as described). 24 -27 The differentiation protocols used are detailed in the Supplementary material online.
FACS
EBs were harvested and dissociated to single cells with collagenase type I (Sigma C-0130) containing 10mg/mL DNAse (CALBIOCHEM# 260913) and trypsin (Sigma T-4799) as previously described. 28 Fluorescenceactivated cell sorting (FACS) and antibodies used for flow cytometry are detailed in the Supplementary material online.
Cell culture
To obtain monolayers of hESC-derived VSMCs, EBs were dissociated on d28 to single cells as described. 27 
IFM
Staining for IFM was carried out in eight-well chamber slides (Lab Tek II), six-well plates or 60 mm dishes (Greiner Bione) with glass coverslips, or frozen sections from Matrigel plugs. Method and antibodies used for IFM are described in the Supplementary material online.
qRT-PCR
RNA was extracted from EBs, monolayers of hESCs-derived VSMCs, and three human primary SMCs (hCSMCs, hASMCs, and hBSMCs) using the PicoPure RNA Isolation Kit (Arcturus). The qRT-PCR method is detailed in the Supplementary material online, with primers used listed in Supplementary material online, Table SI.
Calcium imaging
Passage (P) one to three monolayers of hESC-derived VSMCs (10 4 ) were grown on eight-well glass-bottom chamber slides thinly coated with Matrigel in serum-free conditions. Other cell types tested under identical culture conditions included positive and negative controls consisting of primary hASMCs, hBSMCs, hCSMCs, mouse embryonic fibroblasts (MEFs), and hECs, respectively. Imaging methods, including contraction assays, are detailed in the Supplementary material online.
Angiogenesis assays
A sprouting assay was adapted for use with hESC-derived EBs. 29 EBs on d28 were resuspended in neutralized acid-solubilized 2.5 mg/mL rat tail type-1 collagen (BD Biosciences #354236) and allowed to grow for 7 days in serum-free media. The method is further detailed in the Supplementary material online. Cells were then fixed and immunostained as described above.
Animal studies
All animal procedures were conducted in accordance with appropriate regulatory standards under protocol # 1566.7 approved by the University Health Network Institutional Animal Care and Use Committee (NIH Publication #85-23, revised 1996).
Analysis of vascular integration in vivo
Window chambers were surgically implanted as described previously. of reflexes, and the degree of muscle relaxation. At the time of surgery, and prior to placement of the transparent glass coverslip (12 mm), a concentrated suspension of green fluorescent protein (GFP + ) hESC-derived
VSMCs from P2 in 50% Matrigel (150 000 cells/5 mL) was injected either directly into the retractor muscle of the mouse dorsal skin fold to examine the capacity of the hESCs-derived SMCs to integrate into native blood vessels, or subcutaneously to determine the ability of these cells to incorporate into new blood vessels. Further details regarding these models and the intravital confocal microscopy and 3D image visualization used for their analyses are provided in the Supplementary material online.
Statistical analysis
Data shown are mean + SEM. Statistical analyses were performed by Student's unpaired t-test or One-way ANOVA was followed by Tukey's for multiple comparisons. Analyses were performed on Graphpad Prism v4.0 (GraphPad Software, Inc., La Jolla, CA, USA).
Results
Characterization of SMC gene expression in EBs directed towards cardiac differentiation
Using a staged cardiac-directed serum-free protocol described previously, 27 hESCs were differentiated over 30 days ( Figure 1A) . Briefly, this involved the formation of a population of primitive streak-like hESCs, induction and specification of cardiovascular mesoderm, and subsequent expansion of resulting cardiovascular lineages. Directed differentiation was mediated by specific factors, namely activin A, bone morphogenetic protein 4, basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and dickkopf homolog 1, which have been shown to support cardiomyocyte development. 31 -34 We posited that such a schema would provide the spatiotemporal cues necessary for the development of myocardium-associated coronary artery-like VSMC ( Figure 1A and Supplementary material online, Figure S1A ). Expression of cell type-specific mRNA and protein markers was quantified by qRT-PCR and FACS, respectively. Developing EBs contained cells that expressed VSMC-specific markers by d12, with the mRNA levels of these markers peaking between d14 -22 when compared with undifferentiated hESCs ( Figure 1B) . qRT-PCR revealed the appearance of smooth muscle a-actin (ASMA), calponin-1 (CNN1), transgelin (SM22a), myosin heavy chain polypeptide-11 (MYH11), MYH11 isoforms SM1 and SM2, metavinculin (MVCL), smoothelin A/B (SMTN), and caldesmon-1 (HCAD). By d30, significant reductions in ASMA (27.1 + 6. were detected when compared with levels observed on d14 (n ¼ 3, P , 0.05 for each). While the expression of SM1 and SM2 suggested a 'mature' VSMC phenotype, the embryonic SMC marker MYH10 35 remained abundant. Of note, increased levels of MYH10 have been described in proliferating VSMCs of experimental atherosclerotic lesions, 36 and may be used to characterize myofibroblasts. 36, 37 However, by d30, the MYH10 gene expression level (0.6 + 0.06) was significantly lower than on d14 (1.11 + 0.16), d22 (1.2 + 0.1) and d26 (1.45 + 0.15) of developing EBs (n ¼ 3, P , 0.04 for each). These key findings identified d28 as the developmental stage at which cardiac-directed EBs harbour a 'mature' VSMC population. The EC marker platelet/EC adhesion molecule 1 (PECAM1, a.k.a. CD31) and the fibroblast-specific marker discoidin domain receptor tyrosine kinase 2 (DDR2) were also quantified. Compared with d3, there were significant increases in DDR2 (0.08 + 0.003 vs. 15.5 + 3) starting at d14, and in CD31 (0.001 + 0.0001 vs. 0.3 + 0.09) starting at d26 (Figure 1 , n ¼ 3, P , 0.05 for each). Similar patterns of expression were observed in the H7 hESC line (Supplementary material online, Figure S2 ).
To accurately define the proportion of differentiated VSMCs within EBs, FACS of cells disassociated from whole EBs (from both HES2 and H7 lines) were performed on d13, d21, and d28 ( Figure 2 and Supplementary material online, Figure S2 ). At the earlier time points, cells co-expressing CM-and VSMC-specific markers were identified, a finding consistent with the notion that developing CMs transiently express VSMC genes that are turned off at later stages of development. 38 Based on data suggesting a role for VEGF-R2 in differentiation of VSMC from mouse ESC, 39 we examined the roles played by VEGF and bFGF in the separation of cardiovascular lineages in human EBs. In this experiment, EBs at d11 were maintained in serum-free medium supplemented with VEGF, bFGF, both or neither (Supplementary material online, Figure SIA) , and examined 10 (d21) and 17 (d28) days later by qRT -PCR for SMC, fibroblast, CM, and EC markers. Unlike results obtained when EBs are exposed to both VEGF and bFGF (Figure 1 ), the absence of VEGF (VEGF
resulted in a significant increase in CM gene expression (TNNI3) in d28 EBs (P , 0.05) (Supplementary material online, Figure S1B ). Figure S1C ). In the absence of bFGF (VEGF + /bFGF 2 and VEGF 2 /bFGF 2 ), there were significant decreases in EC gene expression (CD31) in d28 EBs (P , 0.05) (Supplementary material online, Figure S1B ), with FACS indicating that bFGF alone is not sufficient to promote separation of CM and VSMC lineages in d28 EBs (Supplementary material online, Figure S1C ). Together, these data suggest that prolonged exposure to both VEGF and bFGF (d11-d28) is required for complete cardiovascular lineage specification. We then examined whether an enrichment of the ASMA + / TNNI3 
CNN1
, and SM22a staining (Supplementary material online, Figure  S3B ). In addition, beating CMs caused both retraction and detachment of monolayers from this stage (Supplementary material online, Movie S1). These data show that d13 EBs do not harbour bona fide SMCs and are difficult to maintain in monolayers.
Having established d28 as a developmental stage that harbours authentic VSMCs, we next dissociated d28 EBs into single-cell suspensions, plated them at low density, and continued to culture the constituent cell populations in serum-free medium supplemented with VEGF, bFGF, both, or neither (Supplementary material online, Figure S1A ). Over three passages, both VEGF and bFGF were found to be critical for the maintenance and expansion of functional hESC-derived VSMC (Supplementary material online, Figure SIE Figure S4C ). Consistent with this, expression levels of TNNI3, CD31, and DDR2 were significantly decreased in P3 vs. P1 monolayers (*P , 0.001, *P , 0.05, and *P , 0.05, respectively; Figure 3B ). To further assess the nature of enriched hESC-derived VSMCs in monolayer, we compared their gene expression profile to that of cultured primary coronary (hCSMCs), aorta (hASMCs), and bladder (hBSMCs) SMCs. Over three passages, hESC-derived VSMCs express many markers (ASMA, CNN1, SM22a, SMTN, HCAD, g-actin, and myocardin) at levels mostly comparable with those obtained in hCSMC cultures ( Figure 3B and Supplementary material online, Figure S5B ). Of particular interest, P3 hESC-derived VSMCs and hCSMCs shared comparable levels of g-actin, ASMA, and CNN1, a pattern that clearly distinguished them from hASMCs and hBSMCs. We observed similar findings in VSMCs derived from the H7 hESC and Y2-1 iPS lines (Supplementary material online, Figures S2B and S4A) . formed on EBs dissociated on d13, d21, and d28 of development. Representative plots (n ¼ 3 separate experiments) are shown. Three distinct populations, namely ASMA + /TNNI3 + , ASMA 2 /TNNI3 + , and ASMA + /TNNI3 2 were observed at EB d13 and d21. At EB d28, the ASMA + /TNNI3 + cell population was lost, with ASMA and TNNI3 expression restricted to specific SMC and CM populations, respectively. Similar findings were observed with SM22a and CNN1.
hESCs-derived coronary-like vascular SMCs
In hESC-derived VSMCs from EBs d28, a highly homogeneous and stable pattern of the expression of multiple VSMC-specific proteins was also observed over three passages ( Figure 3C and Supplementary material online, Figure S6A ). Furthermore, their pattern of VSMC-specific protein expression was comparable with that of primary hCSMCs, and not detected in primary human ECs or epithelial cells (Supplementary material online, Figure S6 ). IFM also confirmed the loss of ECs and fibroblasts from monolayers ( Figure 3C ). Our H7 and Y2-1-derived SMCs showed similarly homogenous and stable patterns of the expression of multiple SMC-specific proteins (Supplementary material online, Figures S2C and S4B ).
3.3 Both VEGF and bFGF are required for hESC-derived VSMCs to cycle intracellular Ca 21 and contract in response to agonists
An important characteristic of functional VSMCs is their ability to contract in response to agonists, which is mediated by increased intracellular Ca 2+ levels triggering the contractile apparatus. 40 To examine whether hESC-derived VSMCs maintained in serum-free medium supplemented with VEGF, bFGF, both, or neither exhibited functional Ca 2+ responses, cells were loaded with the Ca 2+ -sensitive dye Fluo-4 AM, with their responses to phenylephrine (PE) and norepinephrine (NE) quantified by confocal microscopy. Frame-by-frame image analysis of regions of interest (ROIs) was performed. ROIs corresponded to single Ca 2+ -cycling cells, and their average fluorescence intensities normalized to baseline were plotted over time. Both VEGF and bFGF were essential for hESC-derived VSMC responses to PE and NE, with phasic Ca 2+ cycling activity ( Figure 4A and Supplementary material online, Figure S1E ). On the other hand 'SM-like' cells from d13 EBs had sparse response to PE, no response to NE, with monolayers from this stage showing spontaneous rapid Ca 2+ cycling typical of CMs (Supplementary material online, Figure S3C ). Primary hASMC, hBSMC, and hCSMC were also tested in this manner. hCSMCs responded to PE stimulation, and were equally responsive to NE, a finding also observed in hESC-derived VSMCs. On the other hand, hASMCs responded more vigorously to PE than NE. Overall, a greater proportion of cells in each field were found to cycle Ca human coronary artery ECs (hCAECs) did not spontaneously cycle Ca 2+ and did not respond to either PE or NE (Supplementary material online, Figure S7B ). Responses to agonists were also plotted as maximal fluorescence intensities normalized to baseline for each cell type ( Figure 4B ). The response of hESC-derived VSMCs to NE is more similar to hCSMCs than hASMCs. Overall, hBSMCs had the weakest response to PE and NE. Frequency of Ca 2+ cycling was also quantified for each group ( Figure 4C) Figures S2F, S4D and Movie S3). We next examined primary hCSMCs and hESC-derived VSMCs undergoing physical contractions as manifest by cell shortening in response to agonists. Representative and grouped P3 hESC-derived VSMC and hCSMC data revealed no differences in PE-induced cell shortening (Supplementary material online, Figure S7A ; n ¼ 4-6 cells/group). Together, these results showed that hESC-derived VSMCs obtained from our cardiac-directed protocol have Ca 2+ and contractile responses similar to those of primary hCSMCs, and clearly distinct from those of hASMCs and hBSMCs.
VSMCs from hESC-derived cardiac-directed EBs participate in angiogenesis
To assess the functional capacity of the vascular components of hESC-derived cardiac-directed EBs, we first employed a sprouting angiogenesis assay. This in vitro assay recapitulates angiogenesis in a natural sequence that includes EC sprouting, development of a branched network of angiogenic sprouts, with co-migration of VSMCs and ECs. 41 Upon incubating d13, d21, and d28 EBs in serum-free media supplemented with VEGF and bFGF, we observed sprouting after 4 days in EBs from d21 to d28, and a complex network of interconnected vascular structures after 7 days. Importantly, there was no sprouting observed in EBs from d13 hESCs-derived coronary-like vascular SMCs (Supplementary material online, Figure S5A ). IFM showed that vascular cells migrated away from d21 to d28 EBs and assembled in highly organized cord-like structures ( Figure 5A and Supplementary material online, Figure S2E ). Multiple mature VSMC-specific markers were expressed by cells (VSMCs) aligned alongside cells expressing CD31 (i.e. ECs), including ASMA, CNN1, SM22a, and HCAD in d28 EBs ( Figure 5C ). Of interest, quantitative analysis indicated that 72 + 6% (n ¼ 27) of cells that sprouted out from d21 EBs stained positive for both a SMC-specific marker and CD31 ( Figure 5B) . Conversely, 83 + 6% (n ¼ 17) of cells migrating out from d28 EBs were positive for either a SMC-specific marker (ASMA, CNN1, or SMTN) or CD31. Moreover, outgrowths from d28 EBs contained both CD31-and ASMA-expressing cells that were in direct contact with one another ( Figure 5A ). Having said this, there was no observable difference in sprouting kinetics, branching points or total sprouts between d21 and d28 EBs after 7 days of culture. To support these observations, we also seeded cells dissociated from d28 EBs on Matrigel. As before, hESC-derived SMCs from d28 EBs aligned themselves into networks forming a primitive vascular plexus (Supplementary material online, Figure S8 ). These results suggest that while both d21 and d28 EBs contain vascular cells, the vascular component of hESCderived cardiovascular EBs is more mature at d28, with EC and VSMCs manifesting lineage specification (and presumed greater functional capacity) not seen at d21 (or d13) of EB development.
GFP-labelled hESC-derived VSMCs integrate into native vessels in vivo
To examine the functional capacity of hESC-derived VSMCs in vivo, we next assessed the ability of these cells to incorporate into new vasculature. hESC-derived VSMCs at P2 were generated from a GFP + -expressing HES2 cell line. Cells were injected either directly into the retractor muscle fascia of the dorsal skin fold below a transparent glass coverslip in a window chamber model (to assess integration with existing blood vessels), or subcutaneously (to assess new blood vessel formation) in NOD-SCID mice. Intravital multispectral fluorescence confocal microscopy was used to track the initial migration and subsequent clustering of GFP + hESC-derived VSMCs around native mouse vessels during the first 2 weeks after their delivery. By Week 3 post-injection, there was obvious homing and integration of GFP + hESC-derived VSMCs around host vasculature ( Figure 6A and Supplementary material online, Figure S9 ). Histological analysis of Figure 6B ). These results demonstrate that hESC-derived VSMCs behave analogously to native mature VSMCs in their ability to integrate and contribute to new vessel formation in vivo.
Discussion
Although VSMCs have been previously derived and characterized from hESCs, our results advance this field in several important ways. By employing a developmental approach that recapitulates key events regulating cardiac lineage commitment in the embryo, 27 we have (i) generated hESC-derived VSMCs that are functionally indistinguishable from primary hCSMCs. To our knowledge, we are the first to generate such a specific and functionally distinct VSMC population from hESCs. We have also demonstrated this population to have (ii) a remarkably stable functional phenotype (over at least six passages, Figure 4C ), and (iii) be capable of integrating into both new and existing vasculature in vivo. Although the hESC-derived VSMCs generated by Cheung et al. 23 also appear capable of forming new blood vessels in vivo, these authors added HUVEC to their Matrigel plugs and did not provide evidence of integration with existing host blood vessels. We have also (iv) directly compared and contrasted our hESCderived 'coronary-like' VSMCs with three different primary human SMC cell types, each of which has a different developmental origin (coronary, aorta, and bladder). Despite directing their hESCs to differentiate along three different lineage paths (neuroectoderm, lateral mesoderm, and paraxial mesoderm), Cheung et al. 23 were unable to functionally distinguish the resulting SMC from hASMCs. We believe that this failure to functionally specify their VSMCs may be the result of protocols that do not provide critical organ-specific cues. Additionally, we note that Cheung et al. analysed their lineagespecific SMCs at time points earlier (17d) than our study (28d+, including six passages over an additional 6 weeks). We can only speculate whether longer durations of culture in their chemically defined differentiation protocols would have mimicked the environmental cues inherent in our cardiac-differentiation system. We also demonstrated (v) the importance of both VEGF and bFGF in cardiovascular lineage specification in EBs, and in the enrichment of 'coronary-like' VSMCs in monolayers. The importance of VEGF in our system is not unexpected, as both mouse VSMC progenitors 5 and adult canine VSMCs 39 have been shown to express VEGF-R2.
Indeed, we also found abundant VEGF-R2 mRNA in our SMC system (Supplementary material online, Figure S10A ). Smooth muscle g-actin is an early marker of smooth muscle differentiation. Previous studies indicated that mature SMCs express both a-and g-actin isoforms with a ratio that varies depending on the type of muscle. For instance, VSMCs predominantly express the a-isoforms, whereas the g-isoform predominates in visceral smooth muscle. 42 Our results showed a g/a-actin ratio of 0.25 + 0.02 in HES2, 0.24 + 0.02 in H7, and 0.33 + 0.19 in Y2-1 IPS-derived VSMCs (P3), 0.3 + 0.017 in hCSMCs, 0.0007 + 0.00008 in hASMCs, and 24.7 + 3.6 in hBSMCs. Importantly, we observed no change in this g/a-actin ratio over several passages in hESCs and IPS-derived VSMCs ( Figure 3B , Supplementary material online, Figures S2B and  S4A) , further supporting the stability of this unique cell phenotype.
In conclusion, we have described a chemically defined (serum-free) organ-specific differentiation system allowing for the induction and enrichment of functionally 'mature' coronary-like VSMCs. Comprehensive analyses of gene expression and cell physiology reveal enrichment for a very specific and highly stable SMC lineage derived from lateral plate mesoderm directed towards cardiac tissue. Functional characterizations including contractile responses and integration into new vessel formation in vivo support the opportunity to employ these cells for disease modelling, drug screening, and applications in cell-based therapies for regenerative medicine.
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